Literature DB >> 19825428

Organization of the human embryonic ventral mesencephalon.

Jenny Nelander1, Josephine B Hebsgaard, Malin Parmar.   

Abstract

The neurons in the ventral mesencephalon (VM) are organized into several nuclei consisting of distinct neuronal populations. These include the dopaminergic (DA) neurons of the substania nigra and ventral tegmental area, the oculomotor (OM) neurons that innervate the muscles controlling eye movement, and the reticular neurons of the red nucleus (RN) involved in motor control and coordination reviewed in Puelles (2007). The factors and genes that control the differentiation of the various neuronal populations in the VM have been extensively studied in the mouse and other model organisms but little is known about the progenitors and their protein expression in the developing human brain. In this study we analyze if key regulators identified in rodents are also expressed in the human VM during embryonic development. We report that BLBP and LMX1A mark the floor plate and that FOXA2 is expressed in both the floor plate and basal plate of the human VM. The proneural transcription factors NGN2 and MASH1 are expressed in the ventricular zone of the human VM within and lateral to the floor plate. The post-mitotic DA neurons express TH as well as NURR1 and PITX3. ISL1 and BRN3A can be used to detect the cells of OM and RN, respectively. We show that many key developmental control factors are expressed in a temporal and spatial manner in the human VM essentially corresponding to what has been observed in the mouse. This data therefore suggest similar roles for these factors also in human VM development and dopamine neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825428     DOI: 10.1016/j.gep.2009.10.002

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  13 in total

1.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

2.  Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

Review 3.  MicroRNAs and deregulated gene expression networks in neurodegeneration.

Authors:  Kai-Christian Sonntag
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

4.  Detailed expression analysis of regulatory genes in the early developing human neural tube.

Authors:  Ulrika Marklund; Zhanna Alekseenko; Elisabet Andersson; Scott Falci; Magnus Westgren; Thomas Perlmann; Anthony Graham; Erik Sundström; Johan Ericson
Journal:  Stem Cells Dev       Date:  2013-10-08       Impact factor: 3.272

5.  Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

Authors:  Oliver Cooper; Gunnar Hargus; Michela Deleidi; Alexandra Blak; Teresia Osborn; Elizabeth Marlow; Kristen Lee; Adam Levy; Eduardo Perez-Torres; Alyssa Yow; Ole Isacson
Journal:  Mol Cell Neurosci       Date:  2010-07-24       Impact factor: 4.314

6.  Specification of midbrain dopamine neurons from primate pluripotent stem cells.

Authors:  Jiajie Xi; Yan Liu; Huisheng Liu; Hong Chen; Marina E Emborg; Su-Chun Zhang
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

7.  Gli1 is an inducing factor in generating floor plate progenitor cells from human embryonic stem cells.

Authors:  Mark Denham; Lachlan H Thompson; Jessie Leung; Alice Pébay; Anders Björklund; Mirella Dottori
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

8.  Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome.

Authors:  Hiroko Nobuta; Maria Roberta Cilio; Olivier Danhaive; Hui-Hsin Tsai; Srinivasan Tupal; Sandra M Chang; Alice Murnen; Faith Kreitzer; Verenice Bravo; Catherine Czeisler; Hamza Numan Gokozan; Patrick Gygli; Sean Bush; Debra E Weese-Mayer; Bruce Conklin; Siu-Pok Yee; Eric J Huang; Paul A Gray; David Rowitch; José Javier Otero
Journal:  Acta Neuropathol       Date:  2015-05-15       Impact factor: 17.088

9.  Deriving dopaminergic neurons for clinical use. A practical approach.

Authors:  Rodolfo Gonzalez; Ibon Garitaonandia; Tatiana Abramihina; Gerald K Wambua; Alina Ostrowska; Mathew Brock; Alexander Noskov; Francesca S Boscolo; John S Craw; Louise C Laurent; Evan Y Snyder; Ruslan A Semechkin
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 10.  Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells.

Authors:  Emilía Sif Ásgrímsdóttir; Ernest Arenas
Journal:  Front Cell Dev Biol       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.